Abrhaley, Askale
Giday, Mirutse
Hailu, Asrat
Article History
Received: 2 September 2023
Accepted: 11 September 2024
First Online: 19 September 2024
Declarations
:
: The study was approved by the Scientific and Ethics Review Committee of the Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health of Sciences, Addis Ababa University, Addis Ababa, Ethiopia. Verbal and written informed consent was obtained from each subject prior to participation. Participants were given information about the study and that participation was voluntary. All methods were carried out in accordance with the relevant guidelines and regulations at Addis Ababa University.
: Not applicable.
: The authors declare no competing interests.